#petrelintide — Public Fediverse posts

https://www.europesays.com/ch/?p=61623 Zealand Pharma Boosts Investor Confidence with $200M Buyback and Roche Milestone Payments #buyback #GLP1 #HormonePathway #InvestorConfidence #MilestonePayments #ObesityTrials #petrelintide #ResearchSpending #Roche #ZealandPharma

https://www.europesays.com/ch/57823/ Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management #$3 #advance #amylin #an #analog #and #chronic #for #Management #petrelintide #Pharma #Phase #Roche #to #Trials #Weight #Zealand

https://www.europesays.com/ch/?p=45781 Roche Targets Weight Loss Market with Muscle-Preserving Strategy #GLP1 #loss #Market #MusclePreserving #petrelintide #Roche #Strategy #Targets #Weight

https://www.europesays.com/ch/30458/ Genentech petrelintide sheds 10.7% weight in Phase II #ClinicalTrial #Genentech #Obesity #overweight #petrelintide #PhaseII #RHHBY #Roche #WeightLoss

https://www.europesays.com/ch/27989/ Roche’s Weight-Loss Ambitions Face Reality Check #Ambitions #Check #Face #petrelintide #Phase #Reality #Roche #Roche’s #stock #WeightLoss #Zealand

https://www.europesays.com/ch/27769/ Roche, Zealand’s amylin weight loss drug fails to clear Lilly’s bar #lilly #Obesity #petrelintide #Roche #WeightLossDrugs #ZealandPharma

https://www.europesays.com/ch/27247/ Roche Phase II weight-loss drug trims 10.7% vs placebo #AmylinAnalog #ClinicalData #Obesity #petrelintide #PhaseIITrial #RHHBY #Roche #WeightLoss

https://www.europesays.com/ch/27193/ Roche announces positive Phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity #amylin #an #analog #and #announces #Developed #for #II #living #Obesity #overweight #people #petrelintide #Phase #positive #Results #Roche #With